A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses

Cutis

Volumn 81, Issue 6, 2008, Pages 517-519

  Uliasz, Annemarie ^a   Zeichner, Joshua ^a   Soung, Jennifer ^a   Wong, Vicky ^a   Lebwohl, Mark ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL; FLUOCINONIDE; GLUCOCORTICOID;

ADULT; ARTICLE; ATROPHY; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; EPIDERMIS; HUMAN; INTRADERMAL DRUG ADMINISTRATION; PATHOLOGY; PHASE 4 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE;

ADMINISTRATION, CUTANEOUS; ADULT; ATROPHY; CLOBETASOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EPIDERMIS; FLUOCINONIDE; GLUCOCORTICOIDS; HUMANS; SKIN DISEASES;

EID: 51049111128     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Wong VK, Della Croce C, Schonfeld S, et al. Use and abuse of topical corticosteroids in infections of the skin and related structures. J Drugs Dermatol. 2003;2: 268-276.
2. Long CC, Finlay AY. The finger-tip unit - a new practical measure. Clin Exp Dermatol. 1991;16:444-447.